Literature DB >> 24673868

Stereotactic ablative radiotherapy: what's in a name?

Billy W Loo1, Joe Y Chang2, Laura A Dawson3, Brian D Kavanagh4, Albert C Koong5, Suresh Senan6, Robert D Timmerman7.   

Abstract

Year:  2011        PMID： 24673868     DOI： 10.1016/j.prro.2010.07.001

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN： 1879-8500


× No keyword cloud information.
  14 in total

1.  Stereotactic ablative radiotherapy (SABR) for lung cancer: What does the future hold?

Authors:  Billy W Loo
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

2.  Stereotactic ablative radiotherapy (SABR) in operable early stage non-small cell lung cancer (NSCLC) patients: challenge to claim being undisputed gold standard.

Authors:  Deniz Yalman; Ugur Selek
Journal:  Ann Transl Med       Date:  2015-07

3.  Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

Authors:  C Leigh Moyer; Ryan Phillips; Matthew P Deek; Noura Radwan; Ashley E Ross; Emmanuel S Antonarakis; Diane Reyes; Jean Wright; Stephanie A Terezakis; Daniel Y Song; Curtiland DeVille; Patrick C Walsh; Theodore L DeWeese; Michael Carducci; Edward M Schaeffer; Kenneth J Pienta; Mario Eisenberger; Phuoc T Tran
Journal:  World J Urol       Date:  2018-09-06       Impact factor: 4.226

Review 4.  Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?

Authors:  Esengül Koçak Uzel; Ufuk Abacıoğlu
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 5.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

6.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.

Authors:  Hui Liu; Xu Zhang; Yevgeniy Y Vinogradskiy; Stephen G Swisher; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-27       Impact factor: 7.038

7.  Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.

Authors:  V Duncker-Rohr; U Nestle; F Momm; V Prokic; F Heinemann; M Mix; J Reusch; M-B Messmer; N Marschner; C F Waller; W A Weber; A-L Grosu
Journal:  Strahlenther Onkol       Date:  2013-01       Impact factor: 3.621

Review 8.  Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma.

Authors:  Hong In Yoon; Jinsil Seong
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

9.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.

Authors:  Joe Y Chang; Hui Liu; Peter Balter; Ritsuko Komaki; Zhongxing Liao; James Welsh; Reza J Mehran; Jack A Roth; Stephen G Swisher
Journal:  Radiat Oncol       Date:  2012-09-10       Impact factor: 3.481

10.  Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team.

Authors:  Shervin M Shirvani; Joe Y Chang
Journal:  Cancers (Basel)       Date:  2011-09-01       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.